IRIS
ROMANO, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.249
EU - Europa 2.959
AS - Asia 1.586
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
AF - Africa 9
Totale 7.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.206
IT - Italia 579
CN - Cina 502
IE - Irlanda 468
UA - Ucraina 450
SG - Singapore 447
SE - Svezia 375
GB - Regno Unito 346
TR - Turchia 345
FR - Francia 271
IN - India 220
DE - Germania 181
FI - Finlandia 104
RU - Federazione Russa 81
CA - Canada 32
AT - Austria 25
VN - Vietnam 22
NL - Olanda 15
PE - Perù 15
BE - Belgio 14
HK - Hong Kong 14
CZ - Repubblica Ceca 12
ES - Italia 11
EU - Europa 11
IR - Iran 11
PL - Polonia 11
AU - Australia 9
BZ - Belize 9
BR - Brasile 8
EG - Egitto 8
KR - Corea 7
IL - Israele 6
TW - Taiwan 5
RO - Romania 4
CL - Cile 3
JP - Giappone 3
RS - Serbia 3
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
HR - Croazia 1
MD - Moldavia 1
ME - Montenegro 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.852
Salva come PNG Salva come JPEG
Città #
Chandler 666
Jacksonville 516
Dublin 462
Singapore 393
Southend 268
Princeton 207
Izmir 201
Nanjing 132
Dearborn 112
Ashburn 109
Santa Clara 108
Boardman 107
Chieti 98
Altamura 90
Beijing 88
Wilmington 88
New York 81
Cambridge 80
Ann Arbor 73
Nanchang 63
Rome 40
Montesilvano 34
Los Angeles 31
San Mateo 29
Helsinki 25
Hebei 24
Vienna 24
Washington 24
Woodbridge 24
Dong Ket 22
Shenyang 22
Tianjin 22
Jiaxing 21
Kunming 21
Falls Church 20
Düsseldorf 19
Augusta 18
Houston 18
Toronto 15
Brussels 14
Cornaredo 14
Grevenbroich 14
Montreal 13
Central 12
Changsha 12
Munich 12
Milan 11
Pescara 11
Ica 10
Orange 10
San Buono 10
Seattle 10
Brno 9
Ascoli Piceno 8
Cairo 8
Hangzhou 8
Jinan 8
Lanzhou 7
Leawood 7
Meylan 7
Norwalk 7
Piotrkow Trybunalski 7
Nuremberg 6
Tappahannock 6
Changchun 5
Fuzhou 5
Hefei 5
Lanciano 5
Lima 5
London 5
Madrid 5
Melbourne 5
Redwood City 5
Saint-prix 5
Vasto 5
Amsterdam 4
Ardabil 4
Auburn Hills 4
Bari 4
Chengdu 4
Chicago 4
Guangzhou 4
Haikou 4
Jundiaí 4
Napoli 4
Ningbo 4
Rochester 4
Saint-Saens 4
Shanghai 4
Alessandria 3
Assergi 3
Belgrade 3
Casalbordino 3
Clifton 3
Dacun 3
Edinburgh 3
Frankfurt Am Main 3
Frankfurt am Main 3
Lappeenranta 3
Moscow 3
Totale 4.780
Salva come PNG Salva come JPEG
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 237
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 139
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 138
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 134
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 133
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 130
Establishment and long-term culture of human cystic fibrosis endothelial cells 126
Mechanisms of endothelial cell dysfunction in cystic fibrosis 126
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 121
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 120
Pentraxin 3 and platelet activation in obese patients after gastric banding 119
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 109
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 103
Lipoxins, resolvins, and the resolution of inflammation 98
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 96
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 96
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 95
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 94
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 93
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 91
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 91
Lipoxin receptors 90
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 88
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 88
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 87
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 87
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 86
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 85
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 84
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 84
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 84
Increased soluble CD40L levels in cystic fibrosis 83
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 83
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 83
Transcellular regulation of eicosanoids biosyntesis 82
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 82
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 81
Epigenetic regulation of the formyl peptide receptor 2 gene 80
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 80
Increased levels of soluble P-selectin in hypercholesterolemic patients 79
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 79
Homocysteine modulates the CD40/CD40L system 79
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 79
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 77
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 77
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 76
Leptin increase is associated with markers of the hemostatic system in obese healthy women 76
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 76
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 75
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 74
Induction of functional Lipoxin A4 receptors in HL-60 cells 74
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 73
Reduced platelet mitogenic activity in myeloproliferative disorders 72
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 72
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 71
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 71
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 71
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 71
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 71
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 71
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 69
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 69
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 69
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 68
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 68
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 68
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 68
Lipoxin synthase activity of human platelet 12-Lipoxygenase 67
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 67
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 66
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 65
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 65
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 65
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 64
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 64
Inflammation resolution: does the bone marrow have a say? 64
Ligand bias and its association with pro-resolving actions of melanocortin drugs 64
Lipoxin and aspirin-triggered lipoxins 64
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 63
Lipoxin generation by permeabilized human platelets 62
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 62
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 62
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 62
Human alveolar macrophages generate 15-HETE and can produce lipoxins 61
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 60
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 60
Endothelial perturbation in cystic fibrosis. 59
Lipoxin analogs and lipoxin formation in vivo 59
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 58
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 56
Endotoxic Lipid A induces intracellular Ca2+ increase in human platelets 55
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics 53
NEW GENETIC AND PHARMACOLOGICAL TREATMENTS FOR CYSTIC FIBROSIS 53
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 53
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa 51
Lower platelet count in centenarians correlates with dispersion of the Q-T interval 51
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 51
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 48
The Resolution Approach to Cystic Fibrosis Inflammation 47
Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip: Cystic fibrosis airway chip 45
Totale 7.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.335
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020717 0 0 0 0 88 68 152 116 33 132 121 7
2020/2021807 102 10 104 27 64 126 54 18 124 104 28 46
2021/2022600 9 14 4 145 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/20241.011 78 46 49 30 57 294 185 51 19 46 22 134
2024/2025982 130 381 319 83 69 0 0 0 0 0 0 0
Totale 8.251